Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data.

The Quick Take
Moderna is one of the hottest stocks of the year because of its custom cancer treatment. Full Phase 3 data are set to be revealed this weekend.
Ground Level News gathers headlines from public news feeds. This page shows a short summary only; the full article and all rights belong to MarketWatch.



